sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
27 Nov 2009
361.00CHF
CHF361.00
27 Nov 2009
+0.84%
CHF358.00
CHF355.25
7,957
CHF361.00
CHF352.75
CHF396.00
CHF300.00
0.97
14,969
News
No news stories for this company within the last 30 days.
Press Releases
No news stories for this company within the last 30 days.
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Jornod, Etienne |
Chairman of the Board of Directors, Member of the Management Committee, Chief Executive Officer |
2,929,000 |
| Hirsbrunner, Fritz |
Member of the Management Committee, Vice-CEO, CFO, Head of Finance and Corporate Services Division |
-- |
| Fasel, Paul |
Vice Chairman of the Board of Directors, Lead Director |
282,000 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
CHF2,334.28 |
| Shares Outstanding (Mil.) |
6.47 |
| Float (Mil.) |
4.80 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend (CHF CHF) |
7.00 |
| Payout Ratio(TTM) % |
22.78 |
| |
| Financial Strength |
| Quick Ratio |
0.69 |
| Current Ratio |
1.08 |
| LT Debt/Equity |
81.72 |
| Total Debt/Equity |
128.42 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
11.71 |
| Price/Sales(TTM) |
0.74 |
| Price/Book(TTM) |
3.52 |
| Price/Cash Flow(TTM) |
6.44 |
| |
|
| Per Share Data |
| Earnings(TTM) |
CHF30.89 |
| Sales(TTM) |
CHF486.67 |
| Book Value(MRQ) |
CHF102.58 |
| Cash Flow(TTM) |
CHF55.97 |
| Cash(MRQ) |
CHF9.50 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
33.95 |
| Return on Assets(TTM) |
9.39 |
| Return on Investment(TTM) |
16.06 |
| |
|
| Margins |
| Gross Margin(TTM) % |
27.28 |
| Operating Margin(TTM) % |
9.09 |
| Profit Margin(TTM) % |
6.35 |
|
| |
|